Skip to content

Exploring the role of myeloid-derived suppressor cells in sepsis

Exploring the role of myeloid-derived suppressor cells in sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110841
Enrollment
Unknown
Registered
2025-10-21
Start date
2025-10-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Normal control group:None
Underlying disease group:None
Sepsis group:None

Sponsors

Linyi Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Healthy group: Individuals from hospital health check-up populations, aged >=18 years, with normal results in complete blood count, urinalysis, liver function biochemical markers, kidney function biochemical markers, and myocardial enzyme spectrum. 2. Underlying disease group: Patients aged >=18 years with underlying conditions such as diabetes or cardiovascular/cerebrovascular diseases, but without infection. 3. Infection group: Patients aged >=18 years with underlying conditions such as diabetes or cardiovascular/cerebrovascular diseases, accompanied by infection. 4. Sepsis group: Patients aged >=18 years admitted to our hospital’s intensive care unit with sepsis and underlying conditions such as diabetes or cardiovascular/cerebrovascular diseases.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Age under 18 years; 3. Patients with hematologic malignancies, HIV infection, autoimmune diseases, or those receiving immunosuppressive therapy.

Design outcomes

Primary

MeasureTime frame
Myeloid-derived suppressor cells;

Secondary

MeasureTime frame
Immune-related indicators;Prognostic indicators (e.g., mortality rate, incidence of secondary infections, etc.);MDSC Genome Sequencing;Clinical and diagnostic information (e.g., age, sex, weight/BMI [if available], history of underlying diseases, laboratory tests, etc.);

Countries

China

Contacts

Public ContactLi Guohong

Linyi Central Hospital

honglg521@163.com+86 159 6397 3361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026